Perspectives: The Best Prophylaxis for Primary Arthroplasty

  • Massimo Innocenti
  • Giovanni Riccio
  • Christian Carulli
  • Gabriele Ristori
  • Fabrizio Matassi
  • Roberto Civinini
Chapter

Abstract

An orthopaedic surgery is a clean and successful surgery, as widely demonstrated by several long-term series particularly for hip and knee procedures. The annual worldwide increase in the number of hip and knee implants is leading to a proportional rise of the complication rates: among these, infections to date represent one of the major risks of failure, reaching up to 15 and 25 % of the indications to revision in hip and knee surgery, respectively. It is hard to define a unique protocol of antibiotic prophylaxis in orthopaedic surgery. However, recently the best available evidence has suggested some specific guidelines worldwide accepted. Antibiotic prophylaxis in orthopaedic surgery should be based on the patients’ medical history and health status and set on the local hospital conditions or risk factors; moreover, the duration of the prophylaxis should be varied in cases of prolonged surgical time or intraoperative complications. The antibiotic of first choice should be a first- or second-generation cephalosporin or, in cases of actual specific risks, a glycopeptide, both by intravenous administration. The first dose of antibiotic should be administered 30–60 min before skin incision and always before the use of a tourniquet. Finally, the duration of the prophylaxis should be prolonged at least for 24 h after surgery.

Keywords

Orthopaedic Surgery Antibiotic Prophylaxis Periprosthetic Joint Infection Knee Implant Good Tissue Penetration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. AAOS recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty (2004) www.aaos.org
  2. Al-Buhairan B, Hind H, Hutchinson A (2008) Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 90:915–919CrossRefGoogle Scholar
  3. Al-Maiyah M, Hill D, Bajwa A et al (2005) Bacterial contaminants and antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg Br 87:1256–1258PubMedCrossRefGoogle Scholar
  4. Babkin Y, Raveh D et al (2007) Incidence and risk factors for surgical infection after total knee replacement. Scand J Infect Dis 10:890–895CrossRefGoogle Scholar
  5. Berry DJ, Bozic K (2010) Current practice patterns in primary hip and knee arthroplasty among members of the American Association of Hip and Knee Surgeons. J Arthroplasty 25(6 Suppl):2–4PubMedCrossRefGoogle Scholar
  6. Blom AW, Brown J, Taylor AH et al (2004) Infection after total knee replacement. J Bone Joint Surg Br 86B:688–691CrossRefGoogle Scholar
  7. Bratzler DW et al (2004) Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38:1706–1715PubMedCrossRefGoogle Scholar
  8. Carrega G, Bartolacci V, Burastero G et al (2008) Etiology of prosthetic joint infections in a tertiary care centre in Italy. Infez Med 16(4):204–208PubMedGoogle Scholar
  9. Carulli C, Villano M, Bucciarelli G et al (2011) Painful knee arthroplasty: definition and overview. Clin Cases Miner Bone Metab 8:23–25PubMedCentralPubMedGoogle Scholar
  10. Carulli C, Matassi F, Nistri L et al (2012) Long-term survival of a flat-on-flat total condylar knee arthroplasty fixed with a hybrid cementing technique for tibial components. J Long Term Eff Med Implants 22:305–312PubMedCrossRefGoogle Scholar
  11. Classen DC, Evans RS, Pestotnik SL et al (1992) The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 326:281–286PubMedCrossRefGoogle Scholar
  12. Corbett KL, Losina E, Nti AA et al (2010) Population-based rates of revision of primary total hip arthroplasty: a systematic review. PLoS One 5:e13520PubMedCentralPubMedCrossRefGoogle Scholar
  13. Crabtree TD, Palletier SJ, Gleason TG et al (1999) Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea. Am Surg 65:507–511PubMedGoogle Scholar
  14. Cranny G, Elliot R, Weatherly H et al (2008) A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health Technol Assess 12:1–147CrossRefGoogle Scholar
  15. de Beer J, Petruccelli D, Rotstein C et al (2009) Antibiotic prophylaxis for total joint replacement surgery: results of a survey of Canadian orthopaedic surgeons. Can J Surg 52:E229–E234PubMedCentralPubMedGoogle Scholar
  16. Engesaeter LB, Lie SA, Espehaug B et al (2003) Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis seismically and in bone cement on the revision rate of 22170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 74:644–651PubMedCrossRefGoogle Scholar
  17. Fonseca SN, Kunzle SR, Junqueira MJ et al (2006) Implementing 1-dose antibiotic prophylaxis for prevention of surgical site infection. Arch Surg 141:1109–1113PubMedCrossRefGoogle Scholar
  18. Fulkerson E, Valle CJ, Wise B et al (2006) Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am 88:1231–1237PubMedCrossRefGoogle Scholar
  19. Furuno JP, McGregor JC, Harris AD et al (2006) Identifying groups at high risk for carriage of antibiotic resistant bacteria. Arch Intern Med 166:580–585PubMedCrossRefGoogle Scholar
  20. Gemmel GC, Edwards DI, Weatherly H, Joint working party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association et al (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection in UK. J Antimicrob Chemother 57:589–608CrossRefGoogle Scholar
  21. Glenny AM, Song F (1999) Antimicrobial prophylaxis in total hip replacement: a systematic review. Health Technol Assess 3:1–57PubMedGoogle Scholar
  22. Goyal N, Miller A, Tripathi M et al (2013) Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Joint J 95B:4–9CrossRefGoogle Scholar
  23. Hacek DM, Robb WJ, Paule SM et al (2008) Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 466:1349–1355PubMedCentralPubMedCrossRefGoogle Scholar
  24. Hamilton H, Jamieson J (2008) Deep infection in total hip arthroplasty. Can J Surg 51:111–117PubMedCentralPubMedGoogle Scholar
  25. Heath AF (1991) Antimicrobial prophylaxis for arthroplasty and total joint replacement: discussion and review of published clinical trials. Pharmacotherapy 11:157–163PubMedGoogle Scholar
  26. Innocenti M, Carulli C, Matassi F et al (2014) Total knee arthroplasty in patients with hypersensitivity to metals. Int Orthop 38:329–333PubMedCrossRefGoogle Scholar
  27. Jämsen E, Furnes O, Engesæter LB, Konttinen YT et al (2010) Prevention of deep infection in joint replacement surgery: a review. Acta Orthop 81(6):660–666PubMedCentralPubMedCrossRefGoogle Scholar
  28. Jenkins PJ, Teoh K, Simpson PM et al (2010) Breusch Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br 92:994–998PubMedCrossRefGoogle Scholar
  29. Kalmeijer DM, Coertjens H, van Nieuwland-Bollen PM et al (2002) Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 35:353–358PubMedCrossRefGoogle Scholar
  30. Kock R, Becker K, Cookson B et al (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15:19688PubMedGoogle Scholar
  31. Linee Guida ISS (2011) SNLG Antibioticoprofilassi nell’adultoGoogle Scholar
  32. Matar WY, Jafari MS, Restrepo C et al (2010) Preventing infection in total joint arthroplasty. J Bone Joint Surg Br 92-A(Suppl 2):36–46CrossRefGoogle Scholar
  33. Meehan J, Jamali AA, Nguyen H (2009) Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am 91(10):2480–2490PubMedCrossRefGoogle Scholar
  34. Merollini KMD, Zheng H, Graves N (2013) Most relevant strategies for preventing surgical site infection after total hip arthroplasty: guideline recommendations and expert opinion. Am J Infect Control 41:221–226PubMedCrossRefGoogle Scholar
  35. Nixon M, Jackson B, Varghese P et al (2006) Methicillin-resistant Staphylococcus aureus in orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br 88:812–817PubMedCrossRefGoogle Scholar
  36. Page CP et al (1993) Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 128:79–88PubMedCrossRefGoogle Scholar
  37. Parvizi J (2013) Prosthetic joint infection: practical management guide. Jaypee Brothers Medical Publishers New DelhiGoogle Scholar
  38. Parvizi J, Gehrke T (2013) Proceedings of the international consensus meeting on periprosthetic joint infection. Data Trace Publishing Company, BrooklandvilleGoogle Scholar
  39. Phillips JE, Crane TP, Noy M et al (2006) The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 88:943–948PubMedCrossRefGoogle Scholar
  40. Pulido L, Ghanem E, Joshi A et al (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466:1710–1715PubMedCentralPubMedCrossRefGoogle Scholar
  41. Rao N, Cannella B, Crossett LS et al (2008) A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 466:1343–1348PubMedCentralPubMedCrossRefGoogle Scholar
  42. Ritter MA (2009) The anatomical graduated component total knee replacement. A long-term evaluation with 20-years survival analysis. J Bone Joint Surg Br 91:45–49Google Scholar
  43. Sewick A, Makani A, Wu C et al (2012) Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty? Clin Orthop Relat Res 470:2702–2707PubMedCentralPubMedCrossRefGoogle Scholar
  44. Sharkey PF, Hozack WJ, Rothman RH et al (2002) Why are total knee arthroplasties failing today? Clin Orthop Relat Res 404:7–13PubMedCrossRefGoogle Scholar
  45. Smith EB, Wynne R, Joshi A et al (2012) Is it time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint arthroplasty patients? J Arthroplasty 27(8 Suppl):55–60PubMedCrossRefGoogle Scholar
  46. Soriano A et al (2006) Eur J Clin Microbiol Infect Dis 25:35–38Google Scholar
  47. Southorn PA, Plevak DJ, Wright AJ, Wilson WR (1986) Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc 61:721–724PubMedCrossRefGoogle Scholar
  48. Stefánsdóttir A, Johansson Å, Lidgren L et al (2013) Bacterial colonization and resistance patterns in 133 patients undergoing a primary hip- or knee replacement in Southern Sweden. Acta Orthop 84(1):87–91PubMedCentralPubMedCrossRefGoogle Scholar
  49. Tan JA, Naik VN, Lingard L (2006) Exploring obstacles to proper timing of prophylactic antibiotics for surgical site infections. Qual Saf Health Care 1:32–38CrossRefGoogle Scholar
  50. Tang WM, Chiu KY, Ng TP et al (2003) Efficacy of a single dose of cefazolin as a prophylactic antibiotic in primary arthroplasty. J Arthroplasty 18:714–718PubMedCrossRefGoogle Scholar
  51. Toossi N, Adeli B, Timperley AJ et al (2013) Acetabular components in total hip arthroplasty: is there evidence that cementless fixation is better? J Bone Joint Surg Am 95:168–174PubMedCrossRefGoogle Scholar
  52. Tyllianakis ME, Karageorgos AC, Marangos MN et al (2010) Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents. J Arthroplasty 25(7):1078–1082PubMedCrossRefGoogle Scholar
  53. Van Kasteren ME et al (2007a) Antibiotic prophylaxis and the risk of surgical site infection following total hip arthroplasty; timely administration is the most important factor. Clin Infect Dis 44:92–97Google Scholar
  54. van Kasteren ME, Mannien J, Ott A et al (2007b) Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis 44:921–927PubMedCrossRefGoogle Scholar
  55. Vardakas KZ et al (2005) Perioperative anti-infective prophylaxis with teicoplanin compared to cephalosporins in orthopaedic and vascular surgery involving prosthetic material. Clin Microbiol Infect 11:775–777PubMedCrossRefGoogle Scholar
  56. Villano M, Carulli C, Puccini S et al (2011) Painful knee arthroplasty: surgical approach. Clinical Cases Miner Bone Metab 8:26–28Google Scholar
  57. Willis-Owen CA, Konyves A, Martin DK (2010) Factors affecting the incidence of infection in hip and knee replacement. An analysis of 5277 cases. J Bone Joint Surg Br 92B:1128–1133CrossRefGoogle Scholar
  58. Wymenga A, von Horn J, Theeuwes A et al (1992) Cefuroxime for prevention of post-operative coxitis. One versus three doses tested in a randomized multicenter study of 2651 arthroplasties. Acta Orthop Scand 63:19–24PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Massimo Innocenti
    • 1
  • Giovanni Riccio
    • 2
  • Christian Carulli
    • 1
  • Gabriele Ristori
    • 1
  • Fabrizio Matassi
    • 1
  • Roberto Civinini
    • 1
  1. 1.Orthopaedic ClinicUniversity of FlorenceFlorenceItaly
  2. 2.Regional Center for Infectious Diseases and Septic Orthopedics (Centro Specialistico Regionale Malattie Infettive e Ortopedia Settica, MIOS), Local Healthcare Unit ASL 2 Savonese, Ospedale Santa Maria di MisericordiaAlbengaItaly

Personalised recommendations